My experience working with cancer patients in Ethiopia
Providing dignity and hope for patients and their families is both challenging and rewarding.
Max Tracks: Africa – Lesotho
Learn more about the new chronic myeloid leukemia (CML) program in Lesotho! In 2025, we partnered with local healthcare professionals to provide access to diagnostics, medication, and support services. The first patient began receiving treatment in December.
Africa Region Head Cathy Scheepers will introduce you to Dr. Kabelo Mputsoe, the first oncologist in the country. She was born and raised in Lesotho and has spent the last several years building up the clinic and caring for residents living with cancer. It’s her goal to bring treatment home.
Stay tuned for more behind-the-scenes videos! Cathy and the Max team will be visiting several countries, including Sierra Leone and Ethiopia.
Join our email list for updates and follow along on social media to join the conversation.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Related Articles
Becoming a Mother While Facing Cancer
Having a baby is a major decision, especially for Thao from Vietnam, a cancer patient who had to pause her treatment in order to have a safe pregnancy. Thao shares how she found support through her patient group, her family, and The Max Foundation.
Keeping Our Cool: Developing a Cold-Chain to Further Treatment Access
A “cold-chain” product must remain within a specific temperature range at all times. On days- or weeks-long international shipments, it’s especially challenging (and expensive) to keep medicine at a constant temperature. Despite the inherent challenges, adding cold-chain capability is well worth the effort for the patients we support. By doing so, The Max Foundation will be able to better meet the needs of patients who are unresponsive to tablet therapies.